These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36428530)

  • 1. In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis.
    Wußmann M; Groeber-Becker FK; Riedl S; Alihodzic D; Padaric D; Gerlitz L; Stallinger A; Liegl-Atzwanger B; Zweytick D; Rinner B
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.
    Rinner B; Gandolfi G; Meditz K; Frisch MT; Wagner K; Ciarrocchi A; Torricelli F; Koivuniemi R; Niklander J; Liegl-Atzwanger B; Lohberger B; Heitzer E; Ghaffari-Tabrizi-Wizsy N; Zweytick D; Zalaudek I
    Sci Rep; 2017 May; 7(1):2098. PubMed ID: 28522871
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Riedl S; Rinner B; Schaider H; Liegl-Atzwanger B; Meditz K; Preishuber-Pflügl J; Grissenberger S; Lohner K; Zweytick D
    Oncotarget; 2017 Sep; 8(42):71817-71832. PubMed ID: 29069749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.
    Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D
    Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
    Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.
    Maxian T; Gerlitz L; Riedl S; Rinner B; Zweytick D
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.
    Riedl S; Rinner B; Schaider H; Lohner K; Zweytick D
    Biometals; 2014 Oct; 27(5):981-97. PubMed ID: 24838743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Targeted Radionuclide Therapy Using [
    Akil H; Quintana M; Raymond JH; Billoux T; Benboubker V; Besse S; Auzeloux P; Delmas V; Petit V; Larue L; D'Incan M; Degoul F; Rouanet J
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo.
    Figueiredo CR; Matsuo AL; Azevedo RA; Massaoka MH; Girola N; Polonelli L; Travassos LR
    Sci Rep; 2015 Sep; 5():14310. PubMed ID: 26391685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing.
    Vörsmann H; Groeber F; Walles H; Busch S; Beissert S; Walczak H; Kulms D
    Cell Death Dis; 2013 Jul; 4(7):e719. PubMed ID: 23846221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumoral effect of 4-nerolidylcatechol (4-NC) in NRAS-mutant human melanoma.
    Alves-Fernandes DK; Oliveira ÉA; Hastreiter AA; Faião-Flores F; Felipe-Silva AS; Turato W; Fock RA; Maria-Engler SS; Barros SBM
    Food Chem Toxicol; 2020 Jul; 141():111371. PubMed ID: 32334110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells.
    Ryabaya O; Prokofieva A; Akasov R; Khochenkov D; Emelyanova M; Burov S; Markvicheva E; Inshakov A; Stepanova E
    Biomed Pharmacother; 2019 Jan; 109():2548-2560. PubMed ID: 30551515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of FTIR microspectroscopy for characterization of biomolecular changes in human melanoma cells treated by sesamol and kojic acid.
    Srisayam M; Weerapreeyakul N; Barusrux S; Tanthanuch W; Thumanu K
    J Dermatol Sci; 2014 Mar; 73(3):241-50. PubMed ID: 24296160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
    Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
    J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway.
    Basu D; Salgado CM; Bauer BS; Johnson D; Rundell V; Nikiforova M; Khakoo Y; Gunwaldt LJ; Panigrahy A; Reyes-Múgica M
    Neuro Oncol; 2016 Apr; 18(4):528-37. PubMed ID: 26354928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma.
    Niessner H; Sinnberg T; Kosnopfel C; Smalley KSM; Beck D; Praetorius C; Mai M; Beissert S; Kulms D; Schaller M; Garbe C; Flaherty KT; Westphal D; Wanke I; Meier F
    Clin Cancer Res; 2017 Oct; 23(20):6203-6214. PubMed ID: 28724666
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity.
    Matsuo AL; Tanaka AS; Juliano MA; Rodrigues EG; Travassos LR
    J Mol Med (Berl); 2010 Dec; 88(12):1255-64. PubMed ID: 20802991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.